Moexipril Hydrochloride reol Oral administration of GSK429286A at

Oral administration of GSK429286A at single doses of 3-30 mg/kg dramatically reduces mean arterial pressure in the spontaneously hypertensive rats (SHRs) in a dose-dependent manner

R112 also blocked leukotriene C4 production and all proinflammatory cytokines tested

Z-Leu-D-Leu-Leu-al

PubMed PMID: 29299164

Management of relapsed and refractory multiple myeloma: novel agents

Moexipril Hydrochloride reol Oral administration of GSK429286A atMoexipril is a potent orally active nonsulfhydryl angiotensin converting enzyme inhibitor (ACE inhibitor) which is used for the treatment of hypertension and congestive heart failure. Moexipril can be administered alone or with other antihypertensives or diuretics. It works by inhibiting the conversion of angiotensin I to angiotensin II. Product information CAS Number: 82586 52 5 Molecular Weight: 535. 03 Formula: C27H35ClN2O7 Chemical Name: (3S) 2